Literature DB >> 12842954

Reliability of international normalised ratios from two point of care test systems: comparison with conventional methods.

Leon Poller1, Michelle Keown, Nikhil Chauhan, Anton M H P van den Besselaar, Armando Tripodi, Caroline Shiach, Jorgen Jespersen.   

Abstract

OBJECTIVE: To find out how accurately two point of care test systems--CoaguChek Mini and TAS PT-NC (RapidPointCoag)--display international normalised ratios (INRs).
DESIGN: Comparison of the INRs from the two systems with a "true" INR on a conventional manual test from the same sample of blood.
SETTING: 10 European Concerted Action on Anticoagulation centres. PARTICIPANTS: 600 patients on long term dosage of warfarin. MAIN OUTCOME MEASURES: Comparable results between the different methods.
RESULTS: The mean displayed INR differed by 21.3% between the two point of care test monitoring systems. The INR on one system was 15.2% higher, on average, than the true INR, but on the other system the INR was 7.1% lower. The percentage difference between the mean displayed INR and the true INR at individual centres varied considerably with both systems.
CONCLUSIONS: Improved international sensitivity index calibration of point of care test monitors by their manufacturers is needed, and better methods of quality control of individual instruments by their users are also needed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12842954      PMCID: PMC164241          DOI: 10.1136/bmj.327.7405.30

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  24 in total

Review 1.  Managing oral anticoagulant therapy.

Authors:  J Ansell; J Hirsh; J Dalen; H Bussey; D Anderson; L Poller; A Jacobson; D Deykin; D Matchar
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

Review 2.  Antithrombotic therapy in atrial fibrillation.

Authors:  G W Albers; J E Dalen; A Laupacis; W J Manning; P Petersen; D E Singer
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

3.  Anticoagulation for patients with atrial fibrillation and risk factors for stroke. Warfarin reduces the risk by two thirds, but doctors still aren't prescribing it enough.

Authors:  S J Connolly
Journal:  BMJ       Date:  2000-05-06

4.  European concerted action on anticoagulation. Use of plasma samples to derive international sensitivity index for whole-blood prothrombin time monitors.

Authors:  Leon Poller; Michelle Keown; Nikhil Chauhan; Anton M H P van den Besselaar; Joyce Meeuwisse-Braun; Armando Tripodi; Mariagrazia Clerici; Jørgen Jespersen
Journal:  Clin Chem       Date:  2002-02       Impact factor: 8.327

5.  European Concerted Action on Anticoagulation (ECAA): multicentre international sensitivity index calibration of two types of point-of-care prothrombin time monitor systems.

Authors:  L Poller; M Keown; N Chauhan; A M H P van Den Besselaar; A Tripodi; J Jespersen; C Shiach; M H Horellou; D Dias; N Egberg; J A Iriarte; I Kontopoulou-Griva; B Otridge
Journal:  Br J Haematol       Date:  2002-03       Impact factor: 6.998

6.  European Concerted Action on Anticoagulation (ECAA). Minimum number of centres for reliable International Sensitivity Index calibration of CoaguChek and TAS point-of-care whole blood monitors.

Authors:  L Poller; M Keown; N Chauhan; A M H P van den Besselaar; A Tripodi; C Shiach; J Jespersen
Journal:  Thromb Res       Date:  2002-07-15       Impact factor: 3.944

7.  European Concerted Action on Anticoagulation. Evaluation of a method for International Sensitivity Index calibration of two point-of-care prothrombin time (PT) monitoring systems (CoaguChek Mini and TAS PT-NC) with fresh plasmas based on whole-blood equivalent PT.

Authors:  Leon Poller; Michelle Keown; Nikhil Chauhan; Anton M H P van den Besselaar; Armando Tripodi; Caroline Shiach; Jorgen Jespersen
Journal:  Clin Chem       Date:  2002-10       Impact factor: 8.327

8.  A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management.

Authors:  D A Fitzmaurice; E T Murray; K M Gee; T F Allan; F D R Hobbs
Journal:  J Clin Pathol       Date:  2002-11       Impact factor: 3.411

9.  Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison.

Authors:  M E Cromheecke; M Levi; L P Colly; B J de Mol; M H Prins; B A Hutten; R Mak; K C Keyzers; H R Büller
Journal:  Lancet       Date:  2000-07-08       Impact factor: 79.321

10.  A comparison of INRs determined with a whole blood prothrombin time device and two international reference preparations for thromboplastin.

Authors:  A M van den Besselaar; A M van den Besselar
Journal:  Thromb Haemost       Date:  2000-09       Impact factor: 5.249

View more
  7 in total

1.  INRs and point of care testing.

Authors:  E T Murray; M Greaves
Journal:  BMJ       Date:  2003-07-05

Review 2.  Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Walter Ageno; Alexander S Gallus; Ann Wittkowsky; Mark Crowther; Elaine M Hylek; Gualtiero Palareti
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Two monitoring methods of oral anticoagulant therapy in patients with mechanical heart valve prothesis: a meta-analysis.

Authors:  Zhe Xu; Zhiping Wang; Jingsong Ou; Yingqi Xu; Song Yang; Xi Zhang
Journal:  J Thromb Thrombolysis       Date:  2012-01       Impact factor: 2.300

4.  Impact of a pharmacotherapeutic programme on control and safety of long-term anticoagulation treatment: a controlled follow-up study in Spain.

Authors:  Carmen Duran-Parrondo; Juan M Vazquez-Lago; Ana M Campos-Lopez; Adolfo Figueiras
Journal:  Drug Saf       Date:  2011-06-01       Impact factor: 5.606

5.  A randomized trial comparing INR monitoring devices in patients with anticoagulation self-management: evaluation of a novel error-grid approach.

Authors:  Lars G Hemkens; Kristian M Hilden; Stephan Hartschen; Thomas Kaiser; Ulrike Didjurgeit; Roland Hansen; Ralf Bender; Peter T Sawicki
Journal:  J Thromb Thrombolysis       Date:  2007-10-26       Impact factor: 2.300

6.  Acute physical exercise is safe in patients with primary antiphospholipid syndrome with exclusive venous thrombosis and under oral anticoagulation with warfarin.

Authors:  Carolina Borges Garcia; Luciana Parente Costa Seguro; Luiz Augusto Perandini; Ana Lúcia de Sá Pinto; Fernanda Rodrigues Lima; Carlos Eduardo Negrão; Eloisa Bonfa; Eduardo Ferreira Borba
Journal:  Rheumatol Int       Date:  2014-05-14       Impact factor: 2.631

7.  Prospective Comparison of Point-of-Care Device and Standard Analyzer for Monitoring of International Normalized Ratio in Outpatient Oral Anticoagulant Clinic.

Authors:  Bushra Moiz; Anila Rashid; Muhammad Hasan; Lena Jafri; Ahmed Raheem
Journal:  Clin Appl Thromb Hemost       Date:  2018-01-28       Impact factor: 2.389

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.